Search filters

List of works by Roxanne Hastie

Accuracy of clinical suspicion of growth restriction at term despite a normal growth ultrasound: A retrospective cohort study

scientific article published on 09 January 2020

Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.

scientific article

Acupuncture in pregnancy; primum non nocere

scientific article published on 04 November 2019

Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin.

scientific article published on 7 October 2014

Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin

scientific article published in Scientific Reports

Circulating adrenomedullin mRNA is decreased in women destined to develop term preeclampsia

scientific article published on 10 February 2019

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.

scientific article published on 21 February 2018

Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome

scientific article published on 21 September 2018

Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia

scientific article published on 27 July 2015

Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta

scientific article

Epidermal Growth Factor Rescues Endothelial Dysfunction in Primary Human Tissues In Vitro

scientific article published on 5 December 2016

Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.

scientific article

Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.

scientific article

Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.

scientific article

Maternal mortality at the National Referral Hospital in Honiara, Solomon Islands over a five-year period

scientific article published on 11 September 2019

Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.

scientific article published on 22 December 2015

PSG7 and 9 (Pregnancy-Specific β-1 Glycoproteins 7 and 9): Novel Biomarkers for Preeclampsia

scientific article published on 24 March 2022

Peptides do not prevent cleavage of endoglin to produce soluble endoglin.

scientific article published on 22 October 2014

Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.

scientific article published on 28 September 2015

Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction

scientific article published on 23 January 2017

Screening circulating proteins to identify biomarkers of fetal macrosomia

scientific article published on 18 September 2019

Sulfasalazine decreases soluble fms-like tyrosine kinase-1 secretion potentially via inhibition of upstream placental epidermal growth factor receptor signalling

scientific article published on 10 September 2019

Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.

scientific article

Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy.

scientific article published on 2 February 2018

YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia

scientific article published on 6 July 2015